The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma
Abstract Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of cancer types. An important deficiency in immunooncology today is the lack of a predictive factor to identify this patient group. Myeloi...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2023-10-01
|
| Серія: | BMC Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12885-023-11558-y |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|